High-sensitivity donor-recipient chimerism monitoring can aid in the diagnosis of leukemia relapse and facilitate timely clinical intervention. Our KMRtype kits can be used to determine presence or absence of genetic markers for chimerism monitoring.

By using the qPCR technique, a sensitivity of as low as 0.05% can be reached (20 to 100 fold more sensitive compared to current conventional method using STRs). After genotyping with KMRtype, the KMRtrack kit can be used for monitoring.